
Boston Scientific Approves 2027 Bonus and Performance Share Programs
Boston Scientific Corporation announced the approval of its 2027 Annual Bonus Plan and two performance share programs: the 2027 Relative Total Shareholder Return Performance Share Program and the 2027 Organic Net Sales Growth Performance Share Program. These plans are designed to incentivize eligible employees, including named executive officers, based on performance metrics and align executive compensation with shareholder interests. The bonus plan allows for aggregate bonus pools based on company-wide goals and individual performance, with a maximum payout potential of 225% of an individual's target bonus. The performance share programs are tied to total shareholder return and organic net sales growth, with awards granted as restricted stock units.
Key Highlights
- Boston Scientific approved the 2027 Annual Bonus Plan for the performance year January 1, 2027 - December 31, 2027.
- The 2027 Annual Bonus Plan includes an aggregate bonus pool based on company-wide goals and individual performance modifiers.
- Maximum payout potential for individuals under the 2027 Annual Bonus Plan is 225% of target bonus.
- Approved the 2027 Relative Total Shareholder Return Performance Share Program (2027 rTSR PSP).
- Approved the 2027 Organic Net Sales Growth Performance Share Program (2027 Organic Net Sales PSP).
- Awards under performance share programs are granted as restricted stock units.
- Both bonus and performance share plans are subject to recoupment policies, including the Dodd-Frank Clawback Policy.
Price Impact
More from BSX